Cargando…

Cytarabine/glasdegib: COVID-19 infection and CNS haemorrhage: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195697/ http://dx.doi.org/10.1007/s40278-021-97217-z

Ejemplares similares

Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results
por: Cortes, Jorge E., et al.
Publicado: (2018)

Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
por: Zucenka, Andrius, et al.
Publicado: (2021)

Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists
por: Relias, Valerie, et al.
Publicado: (2020)

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
por: Cortes, Jorge E., et al.
Publicado: (2020)

Cytarabine/dasatinib/rituximab: Reactivation of COVID-19 pneumonia : case report
Publicado: (2020)

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
por: Cortes, Jorge E., et al.
Publicado: (2018)

Cytarabine/daunorubicin: Infections and flare-up of ulcer and cellulitis: 2 case reports
Publicado: (2022)

Cytarabine/venetoclax: Recurrent Corynebacterium bacteraemia: case report
Publicado: (2022)

Multiple drugs: Diffuse alveolar haemorrhage secondary to COVID-19 infection: 2 case reports
Publicado: (2021)

A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy
por: Solem, Caitlyn T., et al.
Publicado: (2020)

Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons
por: Tremblay, Gabriel, et al.
Publicado: (2019)

Cytarabine/daunorubicin: Coronavirus disease-2019 pneumonia: case report
Publicado: (2021)

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
por: Heuser, Michael, et al.
Publicado: (2021)

Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
por: Heuser, Michael, et al.
Publicado: (2021)

Adrenal haemorrhage as a complication of COVID-19 infection
por: Sharrack, Noor, et al.
Publicado: (2020)

Heparin: Multifocal intracerebral haemorrhage and subarachnoid haemorrhage: case report
Publicado: (2021)

Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
por: Regragui, S., et al.
Publicado: (2012)

Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers
por: Shaik, Naveed, et al.
Publicado: (2021)

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors
por: Lin, Swan, et al.
Publicado: (2019)

Glasdegib: A Novel Hedgehog Pathway Inhibitor for Acute Myeloid Leukemia
por: Thompson, Daniel L., et al.
Publicado: (2020)

Glasdegib Dimaleate: Synthesis, Characterization and Comparison of Its Properties with Monomaleate Analogue
por: Peklar, Boris, et al.
Publicado: (2022)

Spontaneous Surgical Intracranial Haemorrhages Associated with SARS-Cov-2 Infection: Case Report
por: Idowu, Jeuel Ogooluwa, et al.
Publicado: (2023)

Early-stage corneal toxicity secondary to high-dose systemic cytarabine: a case report
por: Mito, Tsuyoshi, et al.
Publicado: (2023)

Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report
por: Haméon, Clémence, et al.
Publicado: (2023)

Heparin: Retroperitoneal haemorrhage: case report
Publicado: (2021)

Ibuprofen: Haemorrhagic gastritis: case report
Publicado: (2021)

Heparin: Retroperitoneal haemorrhage: case report
Publicado: (2021)

Enoxaparin-sodium: Haemorrhage: case report
Publicado: (2021)

Heparin: Intracerebral haemorrhage: case report
Publicado: (2020)

Tenecteplase: Haemorrhagic pericarditis: case report
Publicado: (2020)

Heparin: Petechial haemorrhage: case report
Publicado: (2022)

Benzodiazepines/COVID-19-vaccines/levetiracetam: CNS disorders and lack of efficacy: 5 case reports
Publicado: (2022)

Clopidogrel: Diffuse alveolar haemorrhage: case report
Publicado: (2021)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Aspirin/heparin: Intracerebral haemorrhage: case report
Publicado: (2021)

Warfarin overdose: Intracerebral haemorrhage: case report
Publicado: (2021)

Heparin: Nasal haemorrhage and haemoglobinuria: case report
Publicado: (2021)

AZD-1222: Brain haemorrhage: case report
Publicado: (2021)

Enoxaparin-sodium: Intracranial haemorrhage: case report
Publicado: (2020)

Bevacizumab: Diffuse alveolar haemorrhage: case report
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hov0mottbfdegoab3815h2ot2g